VAIA
Virtus Alternative Investment Advisers Portfolio holdings
AUM
$6.71M
This Quarter Return
+15.08%
1 Year Return
+37.54%
3 Year Return
+43.39%
5 Year Return
–
10 Year Return
–
AUM
$6.71M
AUM Growth
+$6.71M
(+23%)
Cap. Flow
+$288K
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
47.64%
Holding
286
New
20
Increased
7
Reduced
247
Closed
6
Top Buys
| 1 |
DGL
Invesco DB Gold Fund
DGL
|
$1.64M |
| 2 |
Comcast
CMCSA
|
$159K |
| 3 |
Charter Communications
CHTR
|
$153K |
| 4 |
Delta Air Lines
DAL
|
$110K |
| 5 |
McDonald's
MCD
|
$89K |
Top Sells
| 1 |
Micron Technology
MU
|
$109K |
| 2 |
Watsco
WSO
|
$100K |
| 3 |
Merck
MRK
|
$66K |
| 4 |
Qualcomm
QCOM
|
$55.1K |
| 5 |
Broadcom
AVGO
|
$53.7K |
Sector Composition
| 1 | Industrials | 16.11% |
| 2 | Technology | 14.44% |
| 3 | Communication Services | 14.32% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Idexx Laboratories
IDXX
$51.8B
| $7K | 0.1% |
15
-15
| -50% | -$7K |
|
127
Immunovant
IMVT
$2.56B
| $7K | 0.1% |
157
-152
| -49% | -$6.78K |
|
128
J&J Snack Foods
JJSF
$2.17B
| $7K | 0.1% |
45
-43
| -49% | -$6.69K |
|
129
Lincoln Electric
LECO
$13.4B
| $7K | 0.1% |
63
-61
| -49% | -$6.78K |
|
130
LeMaitre Vascular
LMAT
$2.15B
| $7K | 0.1% |
173
-167
| -49% | -$6.76K |
|
131
Masimo
MASI
$7.59B
| $7K | 0.1% |
26
-24
| -48% | -$6.46K |
|
132
MGM Resorts International
MGM
$10.8B
| $7K | 0.1% |
+220
| New | +$7K |
|
133
Mesa Laboratories
MLAB
$373M
| $7K | 0.1% |
24
-23
| -49% | -$6.71K |
|
134
Mettler-Toledo International
MTD
$26.8B
| $7K | 0.1% |
6
-5
| -45% | -$5.83K |
|
135
New York Times
NYT
$9.74B
| $7K | 0.1% |
132
-127
| -49% | -$6.74K |
|
136
Okta
OKTA
$16.4B
| $7K | 0.1% |
27
-25
| -48% | -$6.48K |
|
137
Pool Corp
POOL
$11.6B
| $7K | 0.1% |
18
-18
| -50% | -$7K |
|
138
Qualys
QLYS
$4.9B
| $7K | 0.1% |
58
-56
| -49% | -$6.76K |
|
139
Repligen
RGEN
$6.88B
| $7K | 0.1% |
39
-38
| -49% | -$6.82K |
|
140
Robert Half
RHI
$3.8B
| $7K | 0.1% |
107
-103
| -49% | -$6.74K |
|
141
ResMed
RMD
$40.2B
| $7K | 0.1% |
33
-31
| -48% | -$6.58K |
|
142
Revvity
RVTY
$10.5B
| $7K | 0.1% |
47
-45
| -49% | -$6.7K |
|
143
Synopsys
SNPS
$112B
| $7K | 0.1% |
27
-27
| -50% | -$7K |
|
144
Teledyne Technologies
TDY
$25.2B
| $7K | 0.1% |
18
-17
| -49% | -$6.61K |
|
145
Bio-Techne
TECH
$8.5B
| $7K | 0.1% |
23
-22
| -49% | -$6.7K |
|
146
Teleflex
TFX
$5.59B
| $7K | 0.1% |
17
-16
| -48% | -$6.59K |
|
147
Trex
TREX
$6.61B
| $7K | 0.1% |
82
-80
| -49% | -$6.83K |
|
148
Take-Two Interactive
TTWO
$43B
| $7K | 0.1% |
34
-33
| -49% | -$6.79K |
|
149
10x Genomics
TXG
$1.74B
| $7K | 0.1% |
46
-44
| -49% | -$6.7K |
|
150
Tyler Technologies
TYL
$24.4B
| $7K | 0.1% |
16
-16
| -50% | -$7K |
|